Alan B. Sandler
Chief Development Officer at Revolution Medicines, Inc. (RVMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 1SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 2,20056,668 held (−4%) | $200.82 | $442K | -5.5% |
| Oct 1SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,60955,059 held (−3%) | $201.72 | $325K | -5.9% |
| Oct 1SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,00054,059 held (−2%) | $202.81 | $203K | -6.4% |
| Oct 1SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,19952,860 held (−2%) | $203.91 | $244K | -6.9% |
| Oct 1SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 30152,559 held (−1%) | $204.72 | $62K | -7.3% |
| Sep 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 553,204 held (−0%) | $194.96 | $975 | -2.7% |
| Sep 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 33652,868 held (−1%) | $199.30 | $67K | -4.8% |
- Sell
Chief Development Officer Alan B. Sandler sold $442K of RVMD at $200.82 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Alan B. Sandler sold $325K of RVMD at $201.72 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Alan B. Sandler sold $203K of RVMD at $202.81 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Alan B. Sandler sold $244K of RVMD at $203.91 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Alan B. Sandler sold $62K of RVMD at $204.72 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer Alan B. Sandler sold $975 of RVMD at $194.96 — pre-scheduled 10b5-1 plan sale.